Furthermore, Sos et al. grew EPHA3-amplified HCC515 NSCLC cells and demonstrated significant in vivo NSCLC shrinkage after dasatinib treatment [69]. The gene discussed is EPHA3; the disease is non-small cell lung carcinoma.